Ibrexafungerp: A novel oral glucan synthase inhibitor.

MLA

Davis, M. R., et al. “Ibrexafungerp: A Novel Oral Glucan Synthase Inhibitor.” Medical Mycology, vol. 58, no. 5, July 2020, pp. 579–92. EBSCOhost, https://doi.org/10.1093/mmy/myz083.

APA

Davis, M. R., Donnelley, M. A., & Thompson, G. R. (2020). Ibrexafungerp: A novel oral glucan synthase inhibitor. Medical Mycology, 58(5), 579–592. https://doi.org/10.1093/mmy/myz083

Chicago

Davis, M R, M A Donnelley, and G R Thompson. 2020. “Ibrexafungerp: A Novel Oral Glucan Synthase Inhibitor.” Medical Mycology 58 (5): 579–92. doi:10.1093/mmy/myz083.